Enovis (ENOV) Net Equity Issued and Repurchased (2011 - 2026)
Enovis (ENOV) posted quarterly Net Equity Issued and Repurchased of $628000.0 for Q2 2026, up 84.16% year-over-year from $341000.0 in Q2 2025, and up 232.28% quarter-over-quarter from $189000.0 in Q4 2025.
Enovis (ENOV) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
Enovis (ENOV) has reported Net Equity Issued and Repurchased for 16 consecutive years, with $628000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Equity Issued and Repurchased rose 84.16% year-over-year to $628000.0; the TTM figure through Apr 2026 stood at $1.6 million (up 19.42% YoY), while the FY2025 annual figure was $1.3 million, down 29.67% from the prior year.
- Net Equity Issued and Repurchased rose to $628000.0 in Q2 2026 per ENOV's latest filing, from $189000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $3.3 million in Q4 2022 and bottomed at $104000.0 in Q3 2023.
- Historically, Net Equity Issued and Repurchased has averaged $713125.0 across 5 years, with a median of $483000.0 in 2022.
- Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased tumbled 99.83% — and 2024, when it jumped 263.46%.
- Enovis' Net Equity Issued and Repurchased stood at $3.3 million in 2022, then sank by 91.26% to $287000.0 in 2023, then grew by 11.15% to $319000.0 in 2024, then sank by 40.75% to $189000.0 in 2025, then jumped by 232.28% to $628000.0 in 2026.
- Business Quant data shows ENOV's Net Equity Issued and Repurchased at $628000.0 in Q2 2026, $189000.0 in Q4 2025, and $788000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | - |
| 10 | Enovis | 1.52 Bn | 1.50 Bn | 359.25 Mn | 380,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 380,000.00 |
| Jul 3, 2026 | 380,000.00 |
| Apr 3, 2026 | 628,000.00 |
| Apr 3, 2026 | 628,000.00 |
| Oct 3, 2025 | 189,000.00 |
| Oct 3, 2025 | 189,000.00 |
| Jul 4, 2025 | 788,000.00 |
| Jul 4, 2025 | 788,000.00 |
| Apr 4, 2025 | 341,000.00 |
| Apr 4, 2025 | 341,000.00 |
| Dec 31, 2024 | 319,000.00 |
| Dec 31, 2024 | 319,000.00 |
| Sep 27, 2024 | 378,000.00 |
| Sep 27, 2024 | 378,000.00 |
| Jun 28, 2024 | 306,000.00 |
| Jun 28, 2024 | 306,000.00 |
| Mar 29, 2024 | 871,000.00 |
| Mar 29, 2024 | 871,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Dec 31, 2023 | 287,000.00 |